SK bioscience Co.,Ltd. (KRX: 302440)
South Korea
· Delayed Price · Currency is KRW 54,800
-3,000 (-5.19%)
Dec 19, 2024, 3:08 PM KST
SK bioscience Co.,Ltd. Revenue
SK bioscience Co.,Ltd. had revenue of 61.65B KRW in the quarter ending September 30, 2024, a decrease of -73.41%. This brings the company's revenue in the last twelve months to 201.30B, down -51.98% year-over-year. In the year 2023, SK bioscience Co.,Ltd. had annual revenue of 369.51B, down -19.10%.
Revenue (ttm)
201.30B
Revenue Growth
-51.98%
P/S Ratio
21.18
Revenue / Employee
204.57M
Employees
984
Market Cap
4,348.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 369.51B | -87.22B | -19.10% |
| Dec 31, 2022 | 456.73B | -472.28B | -50.84% |
| Dec 31, 2021 | 929.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition